Improvements in productivity and increased participation in daily activities over 52 weeks of certolizumab pegol treatment of rheumatoid arthritis: results of a Belgian observational study-Reference-Cited by-同舟云学术

Improvements in productivity and increased participation in daily activities over 52 weeks of certolizumab pegol treatment of rheumatoid arthritis: results of a Belgian observational study

Published:2018-08-30 Issue:5 Volume:74 Page:342-350
ISSN:1784-3286
Container-title:Acta Clinica Belgica
language:en
Short-container-title:Acta Clinica Belgica

Author:

Westhovens Rene¹²,Ravelingien Isabelle³,Vandevyvere Klaas⁴,Pansar Ingrid⁵,Purcaru Oana⁵,Kumke Thomas⁶,Gyselbrecht Lieve⁷

Affiliation:

1. Department of Development and Regeneration, Skeletal Biology and Engineering Research Center, KU Leuven, Leuven, Belgium

2. Rheumatology, University Hospitals Leuven, Leuven, Belgium

3. Department of Rheumatology, Onze-Lieve-Vrouw Ziekenhuis Aalst, Asse, Aalst, Belgium

4. Reumakliniek MedSeen, Houthulst, Belgium

5. UCB Pharma, Brussels, Belgium

6. UCB Pharma, Monheim am Rhein, Germany

7. Algemeen Stedelijk Ziekenhuis, Aalst, Belgium

Funder

UCB Pharma

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17843286.2018.1509923

Reference47 articles.

1. Anti-TNF therapy: past, present and future

2. Treatment Strategies in Early Rheumatoid Arthritis and Prevention of Rheumatoid Arthritis

3. Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial

4. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

5. Disease activity, handgrip strengths, and hand dexterity in patients with rheumatoid arthritis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and effectiveness of certolizumab pegol in Japanese patients with rheumatoid arthritis: Up to 3-year results from a postmarketing surveillance study;Modern Rheumatology;2024-03-29

2. Methodological aspects of design, analysis and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritis: results of two systematic literature reviews informing EULAR points to consider;RMD Open;2021-02

3. Effectiveness and safety of 12-month certolizumab pegol treatment for axial spondyloarthritis in real-world clinical practice in Europe;Rheumatology;2020-06-25

4. Certolizumab pegol;Reactions Weekly;2019-09-21